Mary Rotunno resigns from Vistagen Therapeutics board effective April 1, 2026

Vistagen Therapeutics, Inc.

Mary Rotunno resigned from the Board of Directors on March 17, 2026, effective April 1, 2026.
No reason for resignation or replacement disclosed in the filing.
Resignation reported under Item 5.02; no other executive changes mentioned.

item 5.02

Vistagen Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-26-019455

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.